Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
Internal medicine (Tokyo, Japan) | 2018-04-01 | PMID 29225269
Uojima Haruki, Murakami Shuko, Nakatani Seigo and 10 more
